Skip to search formSkip to main contentSkip to account menu

vamicamide

Known as: 4-(dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide, 4-dimethylamino-2-phenyl-2-(2-pyridyl)valeramide 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

FK 176

Broader (1)

Pyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle
Objective To evaluate the effects of tolterodine, vamicamide and temiverine, novel antimuscarinic drugs developed for the… 
1995
1995
General pharmacology of the new antimuscarinic compound vamicamide.
The general pharmacology of the new antimuscarinic compound vamicamide (FK176, (+/-)-(2R*, 4R*)-4-dimethylamino-2-phenyl-2- (2… 
1995
1995
Conformational studies on the four stereoisomers of the novel anticholinergic 4-(dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide
SummaryTo interpret differences in the anticholinergic activity among the four steroisomers of 4-(dimethylamino)-2-phenyl-2-(2… 
1994
1994
Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
1. The inhibitory action of vamicamide (FK176, (+/-)-(2R*,4R*)-4-dimethylamino-2-phenyl-2-(2-pyridyl)valeramide, CAS 132373-81-0… 
1994
1994
Population Pharmacokinetics of Vamicamide in Healthy Volunteers
The pharmacokinetic data of vamicamide, a new anticholinergic drug, collected from healthy male subjects were analysed to… 
1994
1994
Population Pharmacodynamics of Vamicamide, a New Anticholinergic Drug, Analyzed by Nonlinear Mixed Effect Modeling: Relationship between the Average Urine Flow Rate and Serum Concentration in Healthy…
The population pharmacodynamics of vamicamide, a new anticholinergic drug, were analyzed by nonlinear mixed effect modeling… 
1993
1993
Determination of the R,R- and S,S-enantiomers of vamicamide in human serum and urine by high-performance liquid chromatography on a Chiral-AGP column.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)